| dc.contributor.author | Alkan, Ali | |
| dc.contributor.author | UZUN ADATEPE, Nurten | |
| dc.contributor.author | Rahmanlar, Hanife | |
| dc.contributor.author | Bayar, Banu | |
| dc.contributor.author | Gursoz, Hakki | |
| dc.contributor.author | Yurtogullari, Sukran | |
| dc.date.accessioned | 2021-03-02T17:07:49Z | |
| dc.date.available | 2021-03-02T17:07:49Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Yurtogullari S., Rahmanlar H., Alkan A., Bayar B., Gursoz H., UZUN ADATEPE N., "A Multifaceted Evaluation of National Off-label Neurology Applications", TURKISH JOURNAL OF NEUROLOGY, cilt.26, sa.3, ss.235-241, 2020 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_2aa2d6df-4edc-42d0-b9d0-7be138800537 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/3613 | |
| dc.identifier.uri | https://doi.org/10.4274/tnd.2020.37791 | |
| dc.description.abstract | Objective: Off-label drug use (OLDU) of neurologic diseases is approved by a regulatory authority, the Turkish Medicines and Medical Devices Agency (TMMDA) in Turkey. It was aimed to investigate the most common neurologic drugs relevant to off-label prescribing and the most prescribed diagnosis, demographic and medical characteristics of patients with OLDU applications in Turkey. | |
| dc.language.iso | eng | |
| dc.subject | Tıp | |
| dc.subject | Nöroloji | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | KLİNİK NEUROLOJİ | |
| dc.title | A Multifaceted Evaluation of National Off-label Neurology Applications | |
| dc.type | Makale | |
| dc.relation.journal | TURKISH JOURNAL OF NEUROLOGY | |
| dc.contributor.department | Ankara Ataturk Training & Research Hospital , , | |
| dc.identifier.volume | 26 | |
| dc.identifier.issue | 3 | |
| dc.identifier.startpage | 235 | |
| dc.identifier.endpage | 241 | |
| dc.contributor.firstauthorID | 2360832 | |